Frontier is a highly collaborative, interdisciplinary research clinic that investigates frontotemporal dementia (FTD). FTD is Australia’s second most common degenerative disease that causes dementia in younger adults. As the first ever research group to concentrate on FTD in Australia, Frontier is dedicated to identifying better ways to diagnose FTD, finding the cause and developing effective treatments for the condition.
Research to understand brain changes in frontotemporal dementia
Our multidisciplinary research examines the neurological, psychological and biological brain function in FTD. As well as how the disease impacts on the lives of patients and their families. Our team is currently investigating:
- Apathy in dementia
- Social cognition and memory changes in frontotemporal dementia
- Progression of structural and functional brain changes in frontotemporal dementia
- Metabolic changes in FTD
- Severity rating scales - how FTD symptoms change over time
- Neuropathology in frontotemporal dementia - cellular changes
- Clinical, imaging and biological markers for early disease identification
- Cognition in motor neurone disease, a condition closely related to frontotemporal dementia
- The impact of FTD on those living with the condition, their carers and family members
- Developing effective support interventions for carers and families
Are you a patient living with FTD? Help us find a cure - get involved in our research.
Professor John Hodges
Professor Olivier Piguet
Professor Glenda Halliday
Associate Professor Muireann Irish
Dr. Fiona Kumfor
Dr. Rebekah Ahmed
Dr. James Burrell
Professor Kirrie Ballard
Dr. Ramon Landin-Romero
Dr. Christian Leyton
Help us impact the lives of people affected with frontotemporal dementia. With your support, our research can make a real difference. We welcome any gift, large or small so make a donation today. Contact Daniel Martins, University of Sydney Director of Development on 02 9351 0987 or .
Diagnostic Tests for Clinicians
We have developed a range of tests to help clinicians accurately assess cognitive function and diagnose frontotemporal dementia in patients, such as the ACE-III and the Frontier Executive Screen test. Access these tests and more here.
If you would like to know when these tests are updated or changed, please with your contact details so we can keep you informed.